• Acetoacetic Acid Sodium Salt: Mechanistic Insights and Trans

  2026-06-18

  Explore the unique mechanistic role of acetoacetic acid sodium salt in energy metabolism research, with advanced insights into its biochemical function beyond routine assay protocols. This article provides a detailed analysis of sodium 3-oxobutanoate’s translational value for diabetes metabolic imbalance studies, contrasting standard workflows with new scientific perspectives.

• Temozolomide in Functional Genomics: Beyond DNA Repair Model

  2026-06-17

  Explore Temozolomide, a small-molecule alkylating agent, as a transformative tool for functional genomics and precision oncology research. This article delivers advanced assay guidance, unique insights into ATRX-deficient model systems, and actionable recommendations for next-generation DNA repair mechanism studies.

• HMGCS2 Downregulation Drives Fibroblast Activation in Lung F

  2026-06-17

  Yang et al. reveal that reduced HMGCS2 in alveolar epithelial cells disrupts lipid metabolism, leading to lysophosphatidylcholine (LysoPC) accumulation and fibroblast activation in pulmonary fibrosis. This mechanistic insight highlights a cellular origin for bioactive lysophospholipids and identifies HMGCS2 as a potential therapeutic target.

• RNA Pol II Degradation Triggers Apoptosis Beyond Transcripti

  2026-06-16

  Harper et al. (2025) reveal that cell death following RNA polymerase II (Pol II) inhibition is not due to passive mRNA decay but is an active, regulated apoptotic response triggered by degradation of the hypophosphorylated Pol IIA form. This insight redefines our understanding of cell death mechanisms in transcriptional inhibition, with implications for mechanistic studies in cell death and inflammation.

• Hydroxytyrosol in Cardiovascular Research: Protocols & Optim

  2026-06-16

  Hydroxytyrosol (4-(2-hydroxyethyl)benzene-1,2-diol) is a high-purity phenolic antioxidant enabling robust, reproducible workflows for cardiovascular and oxidative stress studies. Explore protocol enhancements, troubleshooting strategies, and comparative advantages fueled by evidence from recent olive oil polyphenol research.

• Sodium Orthovanadate: Advanced Control of Tyrosyl Phosphoryl

  2026-06-15

  Explore how Sodium Orthovanadate (Na3VO4) enables advanced preservation and interrogation of protein tyrosyl phosphorylation, with new insights into its critical role in metabolic and insulin signaling assays. This article offers a deeper technical perspective for optimizing phosphorylation-dependent research.

• SGI-1027 Induces Apoptosis in Huh7 Hepatocellular Carcinoma

  2026-06-15

  This study demonstrates that SGI-1027, a non-nucleoside DNMT inhibitor, induces apoptosis in Huh7 human hepatocellular carcinoma cells via a mitochondrial-mediated pathway. The findings clarify the epigenetic mechanism of DNMT inhibition in cancer cell death, providing a valuable benchmark for translational research on DNMT1-targeting agents, including thiopurines like 6-thioguanine.

• JZL184 and the CB1-GLT-1 Axis: Next-Gen Strategies for TBI R

  2026-06-14

  This thought-leadership article explores how JZL184, a selective monoacylglycerol lipase inhibitor, is redefining translational research in traumatic brain injury (TBI) by enabling precise modulation of endocannabinoid signaling. By integrating mechanistic insights from recent studies and offering protocol guidance, the piece charts a course for researchers to move beyond standard assay design and unlock new therapeutic avenues targeting the CB1-CREB-GLT-1 pathway.

• Novel PDK4 Inhibitors: Oral Candidates for Metabolic Disease

  2026-06-13

  This study introduces a new class of allosteric pyruvate dehydrogenase kinase 4 (PDK4) inhibitors, highlighting compound 8c for its nanomolar potency and metabolic stability. The research demonstrates therapeutic potential across metabolic, allergic, and oncological disease models, providing a scaffold for future drug development.

• Chenodeoxycholic Acid (B1908): Reliable FXR Agonist for Rena

  2026-06-12

  This article provides practical, scenario-driven guidance for biomedical researchers utilizing Chenodeoxycholic Acid (SKU B1908) in cell viability, proliferation, and cytotoxicity assays. Drawing on current literature and real-world laboratory challenges, it demonstrates how CDCA supports reproducible FXR and KLF11 pathway studies. Protocol recommendations and product selection insights are included for optimizing experimental reliability.

• GANT61 and GLI Inhibition: New Frontiers in Tumor Immune Mod

  2026-06-12

  Explore the advanced role of GANT61 as a GLI inhibitor in cancer research, with a focus on its impact on tumor immune evasion and translational assay design. This article delivers novel insights and practical guidance beyond protocol optimization.

• Forsythoside E as a PKM2 Inhibitor: Workflows & Troubleshoot

  2026-06-11

  Forsythoside E stands out as a robust PKM2 inhibitor for immunometabolic research, uniquely enabling precise modulation of macrophage polarization and glycolytic pathways. This guide delivers applied workflow strategies, advanced troubleshooting, and protocol enhancements, helping researchers translate mechanistic insights into reliable, high-impact data.

• Rotigotine Hydrochloride in Translational Parkinson’s Resear

  2026-06-11

  Explore how Rotigotine hydrochloride, a dopamine D2/D3 receptor agonist, is transforming translational Parkinson’s disease research. This article delivers unique insight into analytical method selection, impurity management, and advanced assay design for reproducible, clinically relevant results.

• Continuous Rotigotine Delivery for Parkinson’s and RLS: Adva

  2026-06-10

  This review analyzes the development and impact of the rotigotine transdermal system, which enables sustained dopaminergic stimulation in Parkinson’s disease and restless legs syndrome. By addressing both motor and nonmotor symptoms, the study highlights a significant advance in antiparkinsonian therapy and provides a foundation for translational research.

• Dacarbazine: Protocols and Pitfalls in Antineoplastic Chemot

  2026-06-10

  Dacarbazine stands out as a robust antineoplastic chemotherapy drug, enabling highly controlled modeling of cancer DNA damage in both in vitro and translational settings. This guide distills experimental protocols, troubleshooting strategies, and fresh workflow enhancements, empowering researchers to leverage Dacarbazine’s full potential across malignant melanoma, Hodgkin lymphoma, and sarcoma models.

448 records 14/30 page Previous Next First page 上5页 1112131415 下5页 Last page